NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ImmunotherapyYoshihiro Otani, Balveen Kaur, Ji Young Yoo et al.|Clinical Cancer Research|2022Cited by 58
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Ji Young Yoo, Kimberly Rivera-Caraballo et al.|Neuro-Oncology|2024Cited by 22
The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeuticsKimberly Rivera-Caraballo, Ji Young Yoo, Mitra Nair et al.|Molecular Therapy — Oncolytics|2022Cited by 13
esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activationJessica Swanner, Ji Young Yoo, Ji Seon Shim et al.|Molecular Therapy — Oncolytics|2023Cited by 10
DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Sridharan Jayamohan et al.|Neuro-Oncology|2025Cited by 1